Therapeutics Acquisition Corp.
Financial ratios & Valuation

Historical Multiples (2020 – 2020)

2020 TTM Median
Valuation Ratios
Price/Earnings ratio
N/A-2.48-1.24
Price/Sales ratio
N/AN/AN/A
Price/Book Value ratio
N/AN/AN/A
Price/Cash Flow ratio
N/A-2.30-1.15
Price/Free Cash Flow ratio
N/A-2.30-1.15
Price/Earnings Growth ratio
N/A6.843.42
Dividend Yield
N/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/A
Operating Profit Margin
N/AN/AN/A
Pretax Profit Margin
N/AN/AN/A
Net Profit Margin
N/AN/AN/A
Effective Tax Rate
N/A1.03%0.51%
Return on Assets
N/AN/AN/A
Return On Equity
N/A-49.00%-24.50%
Return on Capital Employed
N/AN/AN/A
Liquidity Ratios
Current Ratio
N/AN/AN/A
Quick Ratio
10.20N/A5.10
Cash ratio
9.30N/A4.65
Days of Sales Outstanding
N/AN/AN/A
Days of Inventory outstanding
N/AN/AN/A
Operating Cycle
N/AN/AN/A
Days of Payables Outstanding
N/AN/AN/A
Cash Conversion Cycle
N/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/A
Debt Equity Ratio
N/AN/AN/A
Long-term Debt to Capitalization
N/AN/AN/A
Total Debt to Capitalization
N/AN/AN/A
Interest Coverage Ratio
N/AN/AN/A
Cash Flow to Debt Ratio
N/AN/AN/A
Company Equity Multiplier
1.03N/A0.51
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
N/A10.5
Cash Flow Coverage Ratio
N/AN/AN/A
Short Term Coverage Ratio
N/AN/AN/A
Dividend Payout Ratio
N/AN/AN/A